Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11018303 | American Journal of Obstetrics and Gynecology | 2018 | 8 Pages |
Abstract
Early determination of the anti-Kell titer is sufficient to select pregnancies at increased risk for hemolytic disease of the fetus and newborn with need for transfusion therapy. If the Kell status of the fetus is known to be positive, a titer of â¥4 can be used to target intensive clinical monitoring.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Yolentha M. MSc, Irene T. MD, PhD, Joke M. PhD, Inge L. MD, PhD, Dick MD, PhD, Masja MD, PhD,